Ken Griffin Vbi Vaccines Inc Transaction History

Citadel Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.38 - $22.5 $34,671 - $2.05 Million	91,242 Added 465.07%	110,861 $43,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $215,915 - $6.92 Million	-295,774 Reduced 93.78%	19,619 $14,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $70,777 - $194,100	107,238 Added 51.52%	315,393 $255,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $129,170 - $251,221	101,709 Added 95.55%	208,155 $346,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $99,525 - $145,009	45,034 Added 73.33%	106,446 $249,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $5.23 Million - $6.95 Million	-1,868,317 Reduced 96.82%	61,412 $191,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $4.87 Million - $7.78 Million	1,864,705 Added 2867.72%	1,929,729 $6.46 Million
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $286,277 - $424,988	-98,377 Reduced 60.21%	65,024 $203,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $1.65 Million - $2.68 Million	-765,705 Reduced 82.41%	163,401 $449,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $792,672 - $2.85 Million	911,118 Added 5065.14%	929,106 $2.88 Million
Q1 2020 May 15, 2020	BUY	$0.73 - $1.91 $13,131 - $34,357	17,988 New	17,988 $17,000
Q4 2019 Feb 14, 2020	SELL	$0.48 - $1.38 $59,487 - $171,026	-123,932 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $45,757 - $102,223	97,356 Added 366.33%	123,932 $58,000
Q2 2019 Aug 14, 2019	BUY	$0.65 - $2.12 $5,725 - $18,672	8,808 Added 49.57%	26,576 $31,000
Q4 2018 Feb 14, 2019	BUY	$1.22 - $2.41 $21,676 - $42,820	17,768 New	17,768 $28,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.